Hao‐Jie Zhu - Concepedia

Author

Hao‐Jie Zhu

University of Michigan ORCID

Also Known As

Alexey Nesvizhskii, H Zhu, H-J Zhu, H. Zhu, H.J. Zhu, HAO ZHU, HAO‐JIE ZHU, Hao Zhu, Hao-Jie B. Zhu, Hao-Jie Zhu

298

Publications

6.4K

Citations

H-Index

179

Concepts

All Affiliations

University of Michigan Medical University of South Carolina University of Florida China Pharmaceutical University Nantong University

About

Hao‐Jie Zhu is an author at University of Michigan specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	54	2.7K
2	Social Sciences	11	11	404
3	Natural Sciences	7	7	295
4	Engineering	5	5	404
5	Public Health	2	2	49

Hao‐Jie Zhu

118

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy Yao Wang, Hao‐Jie Zhu, Xiaofeng Hou, Journal of the American College of Cardiology Heart FailureDevice TherapyCardiac MechanicCardiac Resynchronization TherapyCardiac Care	2022	307
Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis Hao‐Jie Zhu, Kennerly S. Patrick, Hong-Jie Yuan, The American Journal of Human Genetics GeneticsMolecular BiologyDysfunctional Carboxylesterase 1PathologyMolecular Basis	2008	220
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy Di Zhang, Guoxun Wang, Xueliang Yu, Nature Nanotechnology Cancer TherapyCrispr/cas GeneCellular Mechanical PropertiesEngineeringCell Modification	2022	214
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana Hao‐Jie Zhu, Jun-Sheng Wang, John S. Markowitz, Journal of Pharmacology and Experimental Therapeutics	2006	190
Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation Hao‐Jie Zhu, Xinwen Wang, Brian E. Gawronski, Journal of Pharmacology and Experimental Therapeutics	2012	187
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018‐2019 Submissions to the US FDA's Office of Clinical Pharmacology Xinyuan Zhang, Yuching Yang, Manuela Grimstein, The Journal of Clinical Pharmacology	2020	178
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein Jun-Sheng Wang, Hao‐Jie Zhu, John S. Markowitz, Psychopharmacology PsychiatryMedicinePsychotropic MedicationAntipsychotic DrugsPsychopharmacology	2006	121
Berberine promotes glucagon-like peptide-1 (7–36) amide secretion in streptozotocin-induced diabetic rats Shou-Si Lu, Yun-Li Yu, Hao‐Jie Zhu, Journal of Endocrinology	2008	112
Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender Jian Shi, Xinwen Wang, Jenny‐Hoa Nguyen, Biochemical Pharmacology Genetic DisorderGeneticsHuman PolymorphismDabigatran Etexilate ActivationGenetic Mechanism	2016	106
An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: A Dose Escalation Study Hao‐Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Drug Metabolism and Disposition	2013	105

Page 1